Searched for
TAKEDA PHARMACEUTICAL COMPANY OF JAPAN
Issues related to India-EFTA trade pact implementation may figure during Piyush Goyal's Switzerland visitCommerce Minister Piyush Goyal visits Switzerland this week. He will discuss issues related to the India-EFTA free trade agreement. The agr...- Samosa, pani puri in Tokyo: Patna's 'Jaggu Dhaba' brings Bihari desi flavours to Japan. Watch videoA taste of home is now available in Tokyo! 'Jaggu Dhaba', a restaurant founded by a man from Patna, is delighting patrons with authentic No...
- Reactor reboot at world's largest nuclear plant highlights flaws in Japan's radioactive waste plansJapan has restarted its largest nuclear power plant to meet energy demands. However, the nation faces a critical challenge: a severe shorta...
- Government may lift price cap on cancer drugs making them costlier by up to 50%India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...
- Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
- Piyush Goyal meets Ernst & Young CEO, discusses India's role in global supply chainsUnion Minister Piyush Goyal said he held a meeting with Janet Truncale, Global Chair and CEO of EY, to discuss India's growing role in glob...
- $10. 6 billion deal: GSK to buy US cancer specialist NuvalentBritish pharmaceutical giant GSK has announced a massive $10.6 billion deal to acquire Nuvalent. This Boston-based company specializes in c...
- Modi, Japan PM Sanae Takaichi may hold talks in Guwahati: HimantaGuwahati may host summit-level talks between Prime Minister Narendra Modi and Japanese Prime Minister Sanae Takaichi. Assam is seeking Japa...
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....
- India's biggest trade bet comes with six red flagsIndia may be adding more trade partners, but its latest FTA report card comes with several red marks. A new study by the Global Trade Resea...
- India willing to open its market to high-quality, innovative pharma products, says commerce ministerIndia is ready to welcome high-quality global pharmaceutical products. This move is in exchange for better market access for Indian drug ex...
- Uzbekistan can provide more incentives to Indian pharma firms, aims to become regional hub for supplyUzbekistan is inviting Indian drug companies to invest more. They are offering better subsidies and technology help. This aims to make Uzbe...
- Japanese PM Takaichi's proposed India trip in July to focus on energy supplies; critical mineralsJapanese Prime Minister Sanae Takaichi may visit India in July for the annual Summit. This visit aims to strengthen cooperation with India,...
- Drug companies directed to step up vigil on adverse reactionsIndia's drug regulator, CDSCO, has mandated all drug companies to establish systems for tracking adverse drug reactions. This move comes am...
- Global Market: Japan's Nikkei surges past 68,000 for first time as AI stocks lead rallyJapan's benchmark Nikkei surged past the 68,000 mark for the first time, rising 2.2% to a record 68,203.79, as strong gains in AI and semic...
- SoftBank overtakes Toyota as Japan's most valuable company on AI boomSoftBank Group has become Japan's most valuable company, surpassing Toyota Motor. This shift highlights investor excitement for artificial ...
- SoftBank overtakes Toyota as Japan's most valuable companyFueled by its significant stake in AI powerhouse OpenAI, SoftBank Group has surged past Toyota to become Japan's most valuable company. The...
- True North buys 25% stake in pharma co EmbioPrivate equity firm True North is investing approximately $50 million in Embio Ltd. Embio manufactures Active Pharmaceutical Ingredients fo...
Load More
